Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update. Clarity Pharmaceuticals has strengthened its production ...

Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update. Clarity Pharmaceuticals Ltd has announced the issuance of ...

Clarity Pharmaceuticals Ltd's (ASX:CU6) top owners are individual investors with 58% stake, while 18% is held by insiders The considerable ownership by individual investors in Clarity Pharmaceuticals ...

Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update. Clarity Pharmaceuticals Ltd. celebrates a major milestone as the CMS finalizes a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update. Clarity Pharmaceuticals Ltd. has announced the issuance of 16,677 new options set to expire on October 1, 2029, with an exercise price ...

The stock that Bell Potter is feeling bullish on is Clarity Pharmaceuticals Ltd (ASX: CU6). It is a clinical stage radiopharmaceutical company that is focused on the treatment of serious diseases.

Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update. Clarity Pharmaceuticals has strengthened its production capabilities by signing agreements with Nucleus RadioPharma to manufacture the ...

HighlightsUnited States Food and Drug Administration (U.S. FDA) provided positive feedback on a pivotal Phase III trial for 64Cu-SAR-bisPSMA diagnostic in prostate cancer patients ...

Clarity Pharmaceuticals Ltd. (AU:CU6) has released an update. Clarity Pharmaceuticals Ltd. celebrates a major milestone as the CMS finalizes a rule for 2025, enhancing reimbursement policies for ...